Burn specialists at Hamilton Health Sciences have completed a world-first medical procedure using exosome therapy to treat severe burn injuries. The team administered this novel biological treatment to Kaitlin Jeffrey, an 18-year-old student injured in a house fire last December.
Exosomes are microscopic particles released by cells that coordinate healing and reduce inflammation. Sourced from lab-grown cells in the United States, approximately one trillion exosomes were injected into the patient's injured areas. The primary clinical objective was to accelerate tissue regeneration and avoid traditional skin grafts, which often result in significant scarring.
Dr. Marc Jeschke, a burn surgeon at McMaster University, led the initiative after securing compassionate use approval from Health Canada. While exosomes have shown promise in wound healing research, this marks their first documented application on human burn patients. Jeffrey received two treatments and demonstrated significantly faster recovery compared to another victim of the same fire who received standard care.
Medical experts note that even optimal skin grafts cannot fully restore normal skin texture, particularly on the face and neck of young patients. Jeffrey described the outcome as miraculous, citing both physical restoration and psychological relief. Researchers at the Centre for Burn Research now aim to establish exosome therapy as a new standard of care across Canada.